Status: current, Defined. Date: 31-Aug 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2632281000168112 | calcium carbonate 160 mg + sodium alginate 500 mg + sodium bicarbonate 267 mg chewable tablet, 32 tablets (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2632291000168110 | sodium alginate 500 mg + sodium bicarbonate 267 mg + calcium carbonate 160 mg chewable tablet, 32 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| sodium alginate 500 mg + sodium bicarbonate 267 mg + calcium carbonate 160 mg chewable tablet, 32 | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| sodium alginate 500 mg + sodium bicarbonate 267 mg + calcium carbonate 160 mg chewable tablet, 32 | has MPUU | sodium alginate 500 mg + sodium bicarbonate 267 mg + calcium carbonate 160 mg chewable tablet | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Gaviscon Double Strength Peppermint chewable tablet, 32 | Is a | True | sodium alginate 500 mg + sodium bicarbonate 267 mg + calcium carbonate 160 mg chewable tablet, 32 | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR